Blue Sail Medical Co., Ltd (SHE: 002382), a medical device company based in China, has announced that it has received marketing approval from the National Medical Products Administration (NMPA) for its Category III medical device, Fastroad. Fastroad is a distal pathway catheter designed for radial artery neurovascular access and was co-developed in collaboration with Beijing Anzhen Hospital.- Flcube.com
Recent news:
-
Sino Biopharmaceutical Submits NDA for Anlotinib and Penpulimab Combo in HCC to NMPA -
Sihuan Pharmaceutical's Huisheng Pharm Strikes Exclusive Deal for Semaglutide Biosimilar in China -
Innovent Biologics' IBI354 Earns Breakthrough Therapy Designation for Ovarian Cancer Treatment -
CDE Includes Double-Crane's Hydroxocobalamine and Sanofi Genzyme's Fitusiran in Rare Disease Care Plan -
Apeiron Therapeutics Initiates Phase Ia/B Study for GTA182 in Solid Tumors with MTAP Deficiency
